Plasmid DNA Manufacturing Market Expected To Reach US$735.67 Million By 2023

https://www.coherentmarketinsights.com/market-insight/plasmid-dna-manufacturing-market-2593
Plasmid DNA Manufacturing Market


Market Overview:

Plasmid DNA manufacturing is a process that involves the production of large quantities of plasmid DNA for various applications, such as gene therapy, vaccines, and protein production. Plasmid DNA offers several advantages, including ease of manufacturing, stability, and the ability to express large amounts of protein. With the increasing demand for advanced therapeutics and biologics, the need for plasmid DNA manufacturing is also growing. The market is driven by factors such as the rising prevalence of genetic diseases, technological advancements in biotechnology, and increased funding for research and development activities in the field of gene therapy.

Market Key Trends:

One key trend in the plasmid DNA manufacturing market is the increasing adoption of gene therapies for the treatment of genetic disorders. Gene therapy holds great promise in the field of healthcare, as it offers the potential to cure genetic diseases by replacing or modifying defective genes. This has led to a growing demand for plasmid DNA manufacturing, as plasmids are used as vectors to deliver therapeutic genes into target cells. The development of novel gene editing technologies, such as CRISPR-Cas9, has further boosted the demand for plasmid DNA manufacturing. These advancements have paved the way for more precise and efficient gene therapies, driving the growth of the plasmid DNA manufacturing market.

The global Plasmid DNA Manufacturing Market Growth is estimated to be valued at US$735.67 Million in 2023 and is expected to exhibit a CAGR of 22.5% over the forecast period 2023-2030, according to a new report published by Coherent Market Insights.

Segment Analysis:

The plasmid DNA manufacturing market can be segmented based on end user and application. In terms of end user, the dominating sub-segment is the biotechnology and pharmaceutical companies. This is mainly due to the increasing demand for plasmid DNA in the development of gene therapies, vaccines, and biologics. Biotechnology and pharmaceutical companies extensively use plasmid DNA for research and development purposes, as well as in the production of therapeutics. These companies have the financial resources and expertise to invest in plasmid DNA manufacturing, making them the dominant end users in the market.

Key Takeaways:

This growth can be attributed to several factors. Firstly, there is a rapidly growing demand for gene therapies and biologics, which require plasmid DNA manufacturing. The advancements in genetic engineering and personalized medicine have increased the need for plasmid DNA for the delivery of therapeutic genes. Additionally, the increasing prevalence of genetic disorders and chronic diseases has fueled the demand for gene therapies, further driving the growth of the plasmid DNA manufacturing market.

From a regional perspective, North America is the fastest-growing and dominating region in the plasmid DNA manufacturing market. The region has a well-established biotechnology and pharmaceutical industry, along with a high demand for gene therapies and biologics. Moreover, North America has favorable regulations and policies supporting genetic research and development, which further boosts the market growth in the region. The presence of key players such as Cobra Biologics and Pharmaceutical Services, VGXI, Inc., and Aldevron in North America also contributes to the dominance of this region in the market.

Key players operating in the plasmid DNA manufacturing market include Cobra Biologics and Pharmaceutical Services (Charles River Laboratories), VGXI, Inc., Aldevron (Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences (LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, and Waisman Biomanufacturing. These key players have a strong presence in the market, offering a wide range of plasmid DNA manufacturing services, and contribute significantly to the growth and development of the market. 

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Image
Agricultural Micronutrients Market Agricultural micronutrients are essential plant nutrients required in small quantities for healthy plant growth and development. Micronutrients such as iron, zinc, manganese, molybdenum, and boron play vital roles in various metabolic functions of crops such as photosynthesis, nitrogen fixation, and enzyme activity. The increasing need to boost crop yields and improve soil fertility has raised the demand for micronutrient fertilizers globally. The growing population and reducing arable land have fueled the need for sustainable agricultural practices, propelling the micronutrients market. The global Agricultural Micronutrients Market is estimated to be valued at US$ 5.19 Bn in 2024 and is expected to exhibit a CAGR of 27.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing adoption of precision farming and digital technologies in the agriculture sector is
Read more